MMSINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

MERIT MEDICAL SYSTEMS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$89.96+0.76 (+0.85%)

Close on Oct 19, 2026

Market cap: $5.40B
P/E (TTM): 37.2
Dividend yield: –

MERIT MEDICAL SYSTEMS INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	1,516	1,357	1,257	1,151	1,075	964	995	883	728	604	542	510	449	394	359	297	257
Cost of Revenue	778	713	673	632	589	563	562	488	402	339	306	284	255	212	194	168	149
Gross Profit	738	643	584	519	485	401	432	395	326	265	236	225	194	182	165	128	109
Research & Development	97	87	83	76	71	58	66	60	51	45	41	37	34	28	22	15	11
Selling, General & Admin	455	400	374	343	336	298	327	276	229	184	156	148	129	122	105	88	65
Operating Expenses	554	488	460	432	424	403	417	336	293	230	198	185	167	152	132	111	76
Operating Income	185	156	124	88	61	-1.56	15	59	33	35	38	40	28	30	33	17	33
Interest Expense	26	31	16	6.34	5.26	9.99	12	10	7.74	8.80	6.23	8.83	8.04	0.60	0.79	0.60	0.03
Interest & Investment Income	–	–	–	–	–	–	–	1.20	0.38	0.08	0.27	0.22	0.26	0.23	0.13	0.03	0.18
Other Non-Operating Income	-14	-5.70	-12	-4.93	-7.00	-12	-13	-9.10	2.81	-9.49	-6.34	-8.59	-8.01	-2.02	-0.32	-0.42	0.25
Merger & Restructuring Charges	5.90	3.10	2.70	7.20	–	–	–	–	–	–	–	–	–	–	–	–	–
Asset Impairment Charges	0.31	0.46	0.27	2.22	4.28	37	24	0.66	0.81	0	0	1.10	8.09	0	0	8.34	0
Gain (Loss) on Sale of Assets	-2.30	-1.49	-5.84	-0.38	-1.30	-2.16	-0.12	-0.63	-0.43	-0.53	0.02	–	–	–	–	–	–
Legal Settlements	–	–	–	–	-10	-19	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	171	150	112	83	54	-13	2.19	50	36	25	31	32	20	28	33	17	33
Income Tax Expense	42	30	18	8.11	5.46	-3.39	-3.26	7.50	8.36	5.27	7.40	8.60	3.27	7.91	9.83	4.33	11
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	–	–	23	17	20	23	12	23
Net Income	128	120	94	75	48	-9.84	5.45	42	28	20	24	23	17	–	23	12	23
Net Income to Common	–	–	–	–	–	–	–	42	28	20	24	23	17	20	23	12	23
EPS (Basic)(per share)	2.17	2.07	1.64	1.31	0.86	-0.18	0.10	0.80	0.56	0.45	0.54	0.53	0.39	0.47	0.59	0.35	0.64
EPS (Diluted)(per share)	2.13	2.03	1.62	1.29	0.84	-0.18	0.10	0.78	0.55	0.45	0.53	0.53	0.39	0.46	0.58	0.35	0.63
Shares Outstanding (Basic, Weighted)(shares)	59	58	58	57	56	55	55	52	49	44	44	43	43	42	39	35	35
Shares Outstanding (Diluted, Weighted)(shares)	60	59	58	58	57	55	56	54	50	45	45	43	43	43	40	36	36
EBITDA	308	258	214	169	145	93	108	128	87	79	75	76	60	52	52	32	45
Provision for Credit Losses	1.26	0.80	0.29	0.08	-0.53	0.16	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 49.5%
Operating margin: 12.8%
Net margin: 9.2%
Return on equity, FY2025: 8.7%

Financial strength

Current ratio: 4.20
Debt to equity: 0.44
Debt to assets: 25.7%
Cash to current liabilities: 169.4%

Valuation

P/E ratio: 37.2
Price to sales: 3.42
Price to book: 3.21
Dividend yield: –